Markets.com Logo

MRNA

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    26.5157$
  • Previous Close
    26.4423$
  • 52 Week Change
    60.52$
  • Day Range
    0.07$
  • 52 Week High/Low
    23.15$ - 83.674$
  • Dividend Per Share
    --
  • Market cap
    10 202 M$
  • EPS
    -2.13
  • Beta
    1.829
  • Volume
    --

About

MRNA.US is the ticker symbol for Moderna, Inc. on the Nasdaq stock exchange. Moderna is a biotechnology company that focuses on messenger RNA (mRNA) therapeutics and vaccines. The company's most well-known product is its COVID-19 vaccine, Spikevax, which played a significant role in combating the pandemic. Moderna is also developing mRNA-based therapies for a range of other diseases, including cancer, infectious diseases, and rare genetic conditions. Investing in MRNA.US means you are investing in the future prospects and performance of Moderna, Inc. as a publicly traded company.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

COVID-19 Vaccine Demand: High demand for Moderna's COVID-19 vaccine significantly drives its stock price upward, conversely, reduced demand decreases the price. Clinical Trial Results: Positive clinical trial outcomes for Moderna's pipeline products, beyond COVID-19, generally lead to stock increases. Negative or inconclusive results can cause the stock to decline. Regulatory Approvals: Approvals from regulatory bodies like the FDA for new vaccines or therapies boost investor confidence and the stock price. Rejections or delays have the opposite effect. Manufacturing Capacity and Supply Chain: Moderna's ability to efficiently produce and distribute vaccines impacts revenue and therefore, stock value. Bottlenecks or disruptions can negatively affect the stock. Competition: The emergence of competing mRNA or other vaccine technologies influences Moderna's market share and pricing power, affecting its stock performance. Financial Performance: Strong revenue, earnings, and positive financial forecasts typically drive the stock price higher. Weak results can cause a decline. Overall Market Conditions: Broader economic trends, market sentiment, and sector-specific (biotech) performance can influence Moderna's stock, regardless of company-specific news.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--